team
Dr. Osborne is a physician–scientist and translational leader in molecular imaging and radioligand theranostics, advancing precision oncology through innovation and strategic program development. He serves as Chief of Molecular Imaging & Therapeutics and Director of the Radioligand Laboratory at Weill Cornell Medicine, where he leads multidisciplinary teams developing next-generation imaging and theranostic platforms with clinical and commercial relevance. Trained at Columbia University (MD/PhD under Nobel Laureate Richard Axel), he previously held senior leadership roles at Memorial Sloan Kettering Cancer Center. Dr. Osborne has authored more than 100 peer-reviewed publications, led pioneering clinical trials, and brings a board- and advisory-ready perspective focused on translation, scalability, and access.
Manuel A. Paris | Co-Founder, MI4
Manuel A. Paris is a transformational healthcare executive with more than two decades of progressive leadership experience across academic medical centers, integrated health systems, and cancer centers, including leadership roles at Memorial Sloan Kettering Cancer Center, NewYork-Presbyterian, and the University of Florida College of Medicine–Jacksonville. His expertise spans enterprise strategy, financial and operational leadership, regional expansion, and the development of advanced imaging, molecular medicine, and oncology-aligned programs. Recognized for driving organizational transformation, aligning multidisciplinary teams, and scaling complex clinical enterprises, he brings a strategic perspective that connects innovation with operational execution. As Co-Founder of MI4, Mr. Paris focuses on advancing molecular imaging and theranostics through sustainable growth strategies, strategic partnerships, and innovative healthcare delivery models that strengthen access, performance, and patient-centered care.
Dr. Lauren Kriger Groner is a cardiothoracic radiologist, health services researcher, and clinical leader focused on advancing lung cancer screening, early detection, and equitable access to diagnostic care. She serves as Associate Professor of Clinical Radiology and Attending Radiologist at the University of Miami Miller School of Medicine, with research centered on clinical, molecular, and imaging predictors of lung cancer and implementation strategies to increase screening uptake. Dr. Groner’s work bridges clinical practice and community health, addressing barriers to early detection and informing interventions that improve outcomes for diverse populations.
Dr. Andrés Ricaurte-Fajardo is a physician-scientist with expertise in neurology, molecular imaging, and translational medicine. He earned his M.D. from Pontificia Universidad Javeriana in Colombia and completed a postdoctoral fellowship in molecular imaging and therapeutics at Weill Cornell Medicine. Currently pursuing residency training in clinical neurology, his research focuses on theranostics, cerebrovascular and neurodegenerative diseases, and oncologic imaging. His contributions include peer-reviewed publications, international scientific presentations, radiotherapeutic clinical trials, and cancer research advocacy. Recognized for his leadership and commitment to health equity, he brings a global, multidisciplinary perspective to advancing precision medicine and innovative patient care.
Dr. Barbara Raphael is a physician leader with experience spanning clinical practice, program development, and multidisciplinary collaboration within leading academic medical centers, including Memorial Sloan Kettering Cancer Center. Her work has focused on advancing high-quality, oncology-aligned care through thoughtful clinical leadership, strategic planning, and close partnership with physicians, researchers, and operational teams. Known for a rigorous, patient-centered approach, Dr. Raphael brings a systems perspective to improving care delivery, supporting institutional excellence, and strengthening performance in complex, specialized healthcare environments.
Dr. Reed Omary is a physician leader, interventional radiologist, and innovator with experience spanning academic medicine, clinical program leadership, and healthcare entrepreneurship. He has held senior leadership roles within academic medical centers, including serving as a department chair, and is widely recognized for advancing minimally invasive therapies, innovation strategy, and physician engagement. Dr. Omary brings a systems-oriented perspective to healthcare transformation, with a focus on clinical excellence, innovation, and healthcare sustainability—aligning quality, value, and long-term impact to improve patient care and organizational performance.
